Suggestions for Radiation Oncologists during the COVID-19 Pandemic

SARS-CoV-2 pandemic and COVID-19 diffusion have recently become an international public health emergency. Cancer patients, as a frail population, are particularly exposed to the risk related to infections. The clinical decision-making process and the organizational workflow of radiotherapy departmen...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2020, Vol.2020 (2020), p.1-4
Main Authors: De Bari, Berardino, Siano, Marco, Kochbati, Lotfi, Franco, Pierfrancesco
Format: Article
Language:English
Subjects:
Betacoronavirus
Breast cancer
Breast Neoplasms - complications
Breast Neoplasms - radiotherapy
Cancer therapies
Clinical Decision-Making
Coronavirus Infections - complications
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Decision making
Departments
Distance learning
Dosimetry
Fatalities
Female
Health aspects
Health risks
Humans
Infection Control - methods
Infections
Metastasis
Neoplasms - complications
Neoplasms - radiotherapy
Older people
Oncology
Pandemics
Patients
Pneumonia, Viral - complications
Pneumonia, Viral - epidemiology
Prostate
Public health
Radiation
Radiation Oncologists
Radiation Oncology
Radiation therapy
Radiotherapy
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Workflow
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SARS-CoV-2 pandemic and COVID-19 diffusion have recently become an international public health emergency. Cancer patients, as a frail population, are particularly exposed to the risk related to infections. The clinical decision-making process and the organizational workflow of radiotherapy department should be revised in the light of the critical situation. We herein provide practical suggestions derived from the available literature and discussed during an online session held within the e-learning educational program of the European School of Oncology on March 31st 2020.
ISSN:2314-6133
2314-6141
DOI:10.1155/2020/4892382